Shearman And Sterling

News May 13, 2020

Quest Diagnostics Incorporated’s $550 Million Senior Notes Offering

Shearman & Sterling represented Quest Diagnostics Incorporated in a shelf takedown of $550 million aggregate principal amount of its 2.800 percent senior notes due 2031. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Mizuho Securities USA LLC acted as joint book-running managers for the offering. 

Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.

The Sterling & Shearman team below also included associate Polina Pristupa.

The Team